Indication: Cystic Fibrosis

A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)

Sub-indication: Cystic Fibrosis

Drug Study

Principal Investigator: Ronald L. Morton, M.D.
Norton Children's Pulmonology, affiliated with the UofL School of Medicine

Sponsor: Cystic Fibrosis Foundation, Inc. (CFF)

Search our entire site.